Science and pragmatism in the treatment and prevention of neutropenic infection

被引:73
作者
Klastersky, J
机构
[1] Univ Libre Bruxelles, Serv Med Interne, B-1000 Brussels, Belgium
[2] Univ Libre Bruxelles, Lab Invest Clin H Tagnon, Inst Jules Bordet, Ctr Tumeurs, B-1000 Brussels, Belgium
关键词
D O I
10.1093/jac/41.suppl_4.13
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The following aspects of the management of patients with granulocytopenia and fever are reviewed in this article: adaptation of initial antibiotic regimens to the recent changes in the most common causative pathogens (namely a change from Gram-negative bacteria to Grampositive bacteria and fungi); subsequent modifications of the empirically administered treatments; improvement of the host's defence by reducing the duration of neutropenia; and indications for out patient therapy of febrile episodes.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 65 条
[1]  
[Anonymous], 1984, J Infect Dis, V150, P372
[2]  
[Anonymous], 1991, J Infect Dis, V163, P951
[3]  
[Anonymous], 1978, J INFECT DIS
[4]   PREVENTION OF GRAM-POSITIVE INFECTIONS AFTER BONE-MARROW TRANSPLANTATION BY SYSTEMIC VANCOMYCIN - A PROSPECTIVE, RANDOMIZED TRIAL [J].
ATTAL, M ;
SCHLAIFER, D ;
RUBIE, H ;
HUGUET, F ;
CHARLET, JP ;
BLOOM, E ;
LEMOZY, J ;
MASSIP, P ;
PRIS, J ;
LAURENT, G .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (05) :865-870
[5]   STREPTOCOCCAL AND ENTEROCOCCAL BACTEREMIA IN PATIENTS WITH CANCER [J].
AWADA, A ;
VANDERAUWERA, P ;
MEUNIER, F ;
DANEAU, D ;
KLASTERSKY, J .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :33-48
[6]   IS RESISTANT ESCHERICHIA-COLI BACTEREMIA AN INEVITABLE OUTCOME FOR NEUTROPENIC PATIENTS RECEIVING A FLUOROQUINOLONE AS PROPHYLAXIS - RESPONSE [J].
BALL, P .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) :561-563
[7]   AEROSOL AMPHOTERICIN-B FOR PREVENTION OF INVASIVE PULMONARY ASPERGILLOSIS [J].
BEYER, J ;
BARZEN, G ;
RISSE, G ;
WEYER, C ;
MIKSITS, K ;
DULLENKOPF, K ;
HUHN, D ;
SIEGERT, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1367-1369
[8]   ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS ADJUVANT THERAPY FOR FUNGAL INFECTION IN PATIENTS WITH CANCER [J].
BODEY, GP ;
ANAISSIE, E ;
GUTTERMAN, J ;
VADHANRAJ, S .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (04) :705-707
[9]  
BODEY GP, 1972, CANCER-AM CANCER SOC, V29, P1697, DOI 10.1002/1097-0142(197206)29:6<1697::AID-CNCR2820290638>3.0.CO
[10]  
2-K